Effects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol
Clinical Evaluation of the DOse of Erythropoietins Study Group (C.E. DOSE), Giovanni FM StrippoliVolume:
11
Language:
english
DOI:
10.1186/1745-6215-11-70
Date:
December, 2010
File:
PDF, 408 KB
english, 2010